7 min listen
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
FromThe Lancet Gastroenterology & Hepatology in conversation with
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
FromThe Lancet Gastroenterology & Hepatology in conversation with
ratings:
Length:
17 minutes
Released:
Mar 12, 2024
Format:
Podcast episode
Description
Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Mar 12, 2024
Format:
Podcast episode
Titles in the series (74)
HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017 by The Lancet Gastroenterology & Hepatology in conversation with